REVBIO, INC. filed an amended Form D with the Securities and Exchange Commission on 2026-10-02.
REVBIO, INC. filed an amended Form D notice of an exempt securities offering with the SEC on October 2, 2026. The filing reports $14.99M sold. Its industry group is Other Health Care. It names BRIAN HESS (Executive Officer, Director), GEORGE KAY (Director), D. ALLEN (Executive Officer, Director) (SEC Form D/A, October 2, 2026).
Sell to companies like REVBIO, INC? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2026-10-02 · the record
Pitching, partnering or investing alongside them? See who really runs and owns REVBIO, INC.
Free to see. No signup.
More on the people and the money behind REVBIO, INC., from the filings we hold.
Other Health Care raises by companies based in Massachusetts, filed in October 2026, largest first.
Get an email when REVBIO, INC. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when REVBIO, INC. raises, hires or launches. No email unless you switch it on.
Watch REVBIO, INC. →Get the full cited report on REVBIO, INC.
What the filing shows about REVBIO, INC.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on REVBIO, INC.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
Saved here on this device in the meantime, so nothing is lost either way.
Full funding history for REVBIO, INC. →
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
A hollow marker is an amendment (Form D/A); a solid one is an original Form D. The larger marker is the filing this page is about.
Trailing twelve months. 866 filings in Other Health Care, totalled by week. The dot is this raise, $14.99M, on the same scale — one filing against the whole group's total, so it sits low by construction.
Checked away from the filing. What is below does not come from the record on sec.gov.
TETRANITE is a regenerative bone glue. Bioengineered for a body of applications, TETRANITE® promises to transform bone repair.
The title and description the site itself served, answering 200. Not a cached copy and not the company's directory entry — what was live when we asked.
Brian Hess is named as Executive Officer and Director on the Form D that REVBIO, INC. filed with the SEC on 2 October 2026, one of 4 people that filing names.
George Kay is named as Director on the Form D that REVBIO, INC. filed with the SEC on 2 October 2026, one of 4 people that filing names.
D. Allen is named as Executive Officer and Director on the Form D that REVBIO, INC. filed with the SEC on 2 October 2026, one of 4 people that filing names.
Kevin Foley is named as Director on the Form D that REVBIO, INC. filed with the SEC on 2 October 2026, one of 4 people that filing names.
4 people named on the filing — 2 holding an executive role and 2 as directors only.
Named as of the 2026-10-02 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about REVBIO, INC.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on REVBIO, INC.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on REVBIO, INC. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist REVBIO, INC.You get an alert in MentionFox the next time this company shows up.
If you're behind REVBIO, INC.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov, and from the company's own site, read directly on 2026-10-03 (revbio.com).
Each opens in a new tab, filled in for REVBIO, INC.. With no account yet, you sign up free and land on the result.
https://mentionfox.com/funding/revbio-inc-form-d-000001